Grip Strength as a Longevity Biomarker: What Large Cohorts Show

By Dr. Ryan Kneessi, ND · Move Forward Natural Health, Odenton, MD · Last reviewed: October 16, 2026

When people think about longevity labs, they usually picture blood tests: inflammation markers, metabolic panels, or hormone levels. Those matter. Strength does too, and you can measure it in under a minute with a hand dynamometer. Over the past several years, large population studies have shown that weaker grip often lines up with higher all-cause mortality, which is why grip strength keeps showing up in conversations about functional biomarkers and healthy aging.

Why a simple squeeze test shows up in aging research

Grip strength reflects more than forearm muscles. It tends to track with overall muscle mass, neuromuscular integrity, and how well someone has maintained physical capacity over years of life. That is why it sits next to other functional measures, such as chair stands and walking speed, in research on aging. Blood markers like hs-CRP tell you about systemic inflammation. Grip strength tells you something about reserve and capacity. Both can belong on a thoughtful longevity workup, which is also why we talk about functional lab testing for longevity as a broader picture rather than a single number.

It helps to keep the limits in view. A weak grip does not mean someone will have a short life, and a strong grip does not guarantee a long one. Cohort studies report associations. They do not prove that raising grip strength by itself changes lifespan. Still, when a cheap, repeatable measure keeps lining up with outcomes across countries and age groups, it earns a place on the radar.

What a 28-country cohort found

In 2022, researchers published an open-access analysis from the Survey of Health, Ageing and Retirement in Europe, covering 27 European countries plus Israel. They followed tens of thousands of adults with repeated grip measurements and looked at all-cause and cancer mortality. In fully adjusted models, people in the highest third of handgrip strength had substantially lower all-cause mortality risk than those in the lowest third, with hazard ratios of 0.41 in men and 0.38 in women.

The dose–response pattern mattered as much as the average effect. Incremental increases in grip strength were linked with lower all-cause mortality up to about 42 kg in men and about 25 kg in women. In participants aged 65 and older, the association looked more linear across a wider range. The same study did not find a robust link between grip strength and cancer mortality after careful competing-risk analysis. You can read the free full text here: Associations of handgrip strength with all-cause and cancer mortality in older adults.

What U.S. NHANES data add

A 2023 open-access analysis of NHANES 2011–2014 data looked at 10,470 U.S. adults and used several statistical approaches, including propensity score matching, to test the grip–mortality relationship. Low grip strength, defined in that paper as under 37.4 kg in men and under 24 kg in women, was associated with higher all-cause and cardiovascular mortality. In the lowest quintile compared with higher groups, fully adjusted hazard ratios for all-cause mortality were about 3.45 in men and 3.3 in women. The shape of the relationship was roughly reverse J-shaped, meaning risk rose most clearly at the low end of strength rather than climbing forever as strength fell by tiny amounts.

Grip strength alone was a fairly strong discriminator of mortality risk in that dataset, and combining it with age improved discrimination further. That pattern fits a practical clinical idea: age tells you chronological time, while grip strength adds a functional signal. The free full text is here: Handgrip strength, all-cause mortality, and cardiovascular mortality in NHANES.

Older women, strength, and mortality after accounting for activity

A 2026 open-access cohort study in JAMA Network Open followed 5,472 ambulatory women aged 63 to 99 years for a mean of about 8.4 years. Researchers measured grip strength and chair-stand time, then layered in accelerometer-measured physical activity, sedentary time, walking speed, and C-reactive protein. Even after those adjustments, higher grip strength and faster chair stands remained associated with lower mortality. Women in the highest grip quartile had about a 30 percent lower hazard of death than the lowest quartile after activity and sedentary time were in the model (hazard ratio 0.70; 95% CI 0.61–0.82).

That finding is useful because it pushes back on a common objection: “Isn’t weak grip just a stand-in for people who move less?” In this cohort, strength still mattered after objective movement data were included. Strength and activity are related, yet they are not the same signal. The free full text is here: Muscular strength and mortality in women aged 63 to 99 years.

How to use grip strength without overreading it

In practice, I use grip strength as one functional biomarker in a larger pattern. A single reading is a snapshot. Trends over months matter more, especially if someone’s training, protein intake, sleep, or illness burden has changed. Norms also differ by sex, age, and body size, so cutoffs from one paper should not be copied as a universal rule for every person in front of you.

If grip is low for age and sex, the next questions are usually practical ones. How is overall muscle strength and healthy aging support going? Is resistance training part of the week, or only walking? Are protein targets realistic for the person’s appetite and digestion? Are inflammation, thyroid status, or recovery getting in the way? Those conversations connect naturally to a broader strength-and-recovery plan, without turning one dynamometer reading into a verdict.

Home bathroom scales that claim to estimate “muscle age” are not the same thing as a calibrated handgrip test. If you want a number you can compare over time, ask for a proper dynamometer reading in clinic, or use a consistent device the same way each visit.

What this means for a longevity-minded plan

Large cohorts from Europe and the United States keep pointing in the same direction: weaker grip tracks with higher mortality risk, and stronger grip tracks with lower risk up to a point. That makes grip strength a useful functional biomarker alongside blood work, not a replacement for it. The research still leaves room for humility. These studies are observational. Improving strength is worthwhile for daily function and resilience, yet no single trial proves that raising grip kilograms by itself lengthens life.

A sensible approach is simple. Measure strength. Train it with progressive resistance work that fits your joints and schedule. Support recovery with sleep and adequate protein. Recheck the number the same way you would recheck a lab you care about. Then interpret it in context with the rest of your health story.

Frequently asked questions

Sources

• López-Bueno et al. Associations of handgrip strength with all-cause and cancer mortality in older adults: a prospective cohort study in 28 countries. Age and Ageing. 2022. Free full text on PubMed Central.
• Zhang et al. The association of handgrip strength with all-cause and cardiovascular mortality: NHANES prospective cohort with propensity score matching. Frontiers in Nutrition. 2023. Free full text on PubMed Central.
• LaMonte et al. Muscular Strength and Mortality in Women Aged 63 to 99 Years. JAMA Network Open. 2026. Free full text on PubMed Central.

This article is for educational purposes only and is not medical advice. It does not replace an individual evaluation. Talk with your healthcare provider before starting a new exercise program or changing medications, especially if you are pregnant, nursing, or managing a health condition.